Allergy Diagnostics and Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030

Allergy Diagnostics and Therapeutics Trends and Forecast

The future of the global allergy diagnostics and therapeutics market looks promising with opportunities in the food, inhaled, and drug markets. The global allergy diagnostics and therapeutics market is expected to reach an estimated $55.4 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing allergy disorders in children and geriatric population, growing adoption of IDV techniques, and improvement in diagnostic tools.

A more than 150-page report is developed to help in your business decisions.

Allergy Diagnostics and Therapeutics by Segment

The study includes a forecast for the global allergy diagnostics and therapeutics by product type, allergen type, test type, drug class, and region.

Allergy Diagnostics and Therapeutics Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables
• Services

Allergy Diagnostics and Therapeutics Market by Allergen Type [Shipment Analysis by Value from 2018 to 2030]:

• Food
• Inhaled
• Drug

Allergy Diagnostics and Therapeutics Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

• In Vivo Test
• In Vitro Test

Allergy Diagnostics and Therapeutics Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

• Antihistamines
• Decongestants
• Corticosteroids
• Mast Cell Stabilizers
• Leukotriene Inhibitors
• Nasal Anti-Cholinergic
• Immuno-Modulators
• Epinephrine
• Immunotherapy

Allergy Diagnostics and Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Allergy Diagnostics and Therapeutics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies allergy diagnostics and therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the allergy diagnostics and therapeutics companies profiled in this report include-

• R-Biopharm
• Euroimmun Medizinische Labordiagnostika
• Dasit
• Aesku
• Biomerieux
• Thermo Fisher Scientific
• Stallergenes Greer
• Minaris Medical America
• Siemens Healthcare
• Omega Diagnostics

Allergy Diagnostics and Therapeutics Market Insights

Lucintel forecasts that consumables is expected to witness highest growth over the forecast period due to its increasing adoption in the diagnostic testing that makes it indispensable.

Within this market, drug allergies is expected to witness highest growth due to increasing access to treatment and rising awareness of drug allergies among patients.

North America will remain the largest region over the forecast period due to increasing incidences of allergy and favorable government initiatives in the region.

Features of the Global Allergy Diagnostics and Therapeutics Market

Market Size Estimates: Allergy diagnostics and therapeutics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Allergy diagnostics and therapeutics market size by various segments, such as by product type, allergen type, test type, drug class, and region in terms of value ($B).

Regional Analysis: Allergy diagnostics and therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, allergen types, test types, drug classes, and regions for the allergy diagnostics and therapeutics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the allergy diagnostics and therapeutics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the allergy diagnostics and therapeutics market size?

Answer: The global allergy diagnostics and therapeutics market is expected to reach an estimated $55.4 billion by 2030.

Q.2 What is the growth forecast for allergy diagnostics and therapeutics market?

Answer: The global allergy diagnostics and therapeutics market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the allergy diagnostics and therapeutics market?

Answer: The major drivers for this market are increasing allergy disorders in children and geriatric population, growing adoption of IDV techniques, and improvement in diagnostic tools.

Q4. What are the major segments for allergy diagnostics and therapeutics market?

Answer: The future of the allergy diagnostics and therapeutics market looks promising with opportunities in the food, inhaled, and drug markets.

Q5. Who are the key allergy diagnostics and therapeutics market companies?

Answer: Some of the key allergy diagnostics and therapeutics companies are as follows:

• R-Biopharm
• Euroimmun Medizinische Labordiagnostika
• Dasit
• Aesku
• Biomerieux
• Thermo Fisher Scientific
• Stallergenes Greer
• Minaris Medical America
• Siemens Healthcare
• Omega Diagnostics

Q6. Which allergy diagnostics and therapeutics market segment will be the largest in future?

Answer: Lucintel forecasts that consumables is expected to witness highest growth over the forecast period due to its increasing adoption in the diagnostic testing that makes it indispensable.

Q7. In allergy diagnostics and therapeutics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing incidences of allergy and favorable government initiatives in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the allergy diagnostics and therapeutics market by product type (instruments, consumables, and services), allergen type (food, inhaled, and drug), test type (in vivo test and in vitro test), drug class (antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anti-cholinergic, immuno-modulators, epinephrine, and immunotherapy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?